2-hydroxy-2-methyl-4-oxo-4-thiophen-2-yl-butyric acid | 32176-48-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 酮酸及其衍生物
• 英文名称: 2-hydroxy-2-methyl-4-oxo-4-thiophen-2-yl-butyric acid
• 英文别名: 2-Hydroxy-2-methyl-4-oxo-4-thiophen-2-ylbutanoic acid
• CAS: 32176-48-0
• 化学式: C₉H₁₀O₄S
• 分子量: 214.242
• InChiKey: CQZTVVMHCHAVEG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  103
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-hydroxy-2-methyl-4-oxo-4-thiophen-2-yl-butyric acid 在 一水合肼 作用下， 以 正丁醇 为溶剂， 生成 4-甲基-6-(2-噻吩基)哒嗪-3-酮
  参考文献：
  名称：

  3-Aminopyridazine derivatives with atypical antidepressant, serotonergic and dopaminergic activities

  摘要：

  Minaprine [3-[(beta-morpholinoethyl)amino]-4-methyl-6-phenylpyridazine dihydrochloride] is active in most animal models of depression and exhibits in vivo a dual dopaminomimetic and serotoninomimetic activity profile. In an attempt to dissociate these two effects and to characterize the responsible structural requirements, a series of 47 diversely substituted analogues of minaprine were synthesized and tested for their potential antidepressant, serotonergic, and dopaminergic activities. The structure-activity relationships show that dopaminergic and serotonergic activities can be dissociated. Serotonergic activity appears to be correlated mainly with the substituent in the 4-position of the pyridazine ring whereas the dopaminergic activity appears to be dependent on the presence, or in the formation, of a para-hydroxylated aryl ring in the 6-position of the pyridazine ring.

  DOI：

  10.1021/jm00123a004
• 作为产物：
  描述：

  2-乙酰基噻吩 、 丙酮酸 在 氢氧化钾 作用下， 以 甲醇 、 水 为溶剂， 反应 96.0h， 生成 2-hydroxy-2-methyl-4-oxo-4-thiophen-2-yl-butyric acid
  参考文献：
  名称：

  3-Aminopyridazine derivatives with atypical antidepressant, serotonergic and dopaminergic activities

  摘要：

  Minaprine [3-[(beta-morpholinoethyl)amino]-4-methyl-6-phenylpyridazine dihydrochloride] is active in most animal models of depression and exhibits in vivo a dual dopaminomimetic and serotoninomimetic activity profile. In an attempt to dissociate these two effects and to characterize the responsible structural requirements, a series of 47 diversely substituted analogues of minaprine were synthesized and tested for their potential antidepressant, serotonergic, and dopaminergic activities. The structure-activity relationships show that dopaminergic and serotonergic activities can be dissociated. Serotonergic activity appears to be correlated mainly with the substituent in the 4-position of the pyridazine ring whereas the dopaminergic activity appears to be dependent on the presence, or in the formation, of a para-hydroxylated aryl ring in the 6-position of the pyridazine ring.

  DOI：

  10.1021/jm00123a004

文献信息

• KAN, J. P.;BIZIERE, K.;WERMUTH, C. -G.
  作者：KAN, J. P.、BIZIERE, K.、WERMUTH, C. -G.

  DOI：——

  日期：——
• US4524070A
  申请人：——

  公开号：US4524070A

  公开（公告）日：1985-06-18
• 3-Aminopyridazine derivatives with atypical antidepressant, serotonergic and dopaminergic activities
  作者：Camille Georges Wermuth、Gilbert Schlewer、Jean Jacques Bourguignon、Georges Maghioros、Marie Jeanne Bouchet、Claudine Moire、Jean Paul Kan、Paul Worms、Kathleen Biziere

  DOI：10.1021/jm00123a004

  日期：1989.3

  Minaprine [3-[(beta-morpholinoethyl)amino]-4-methyl-6-phenylpyridazine dihydrochloride] is active in most animal models of depression and exhibits in vivo a dual dopaminomimetic and serotoninomimetic activity profile. In an attempt to dissociate these two effects and to characterize the responsible structural requirements, a series of 47 diversely substituted analogues of minaprine were synthesized and tested for their potential antidepressant, serotonergic, and dopaminergic activities. The structure-activity relationships show that dopaminergic and serotonergic activities can be dissociated. Serotonergic activity appears to be correlated mainly with the substituent in the 4-position of the pyridazine ring whereas the dopaminergic activity appears to be dependent on the presence, or in the formation, of a para-hydroxylated aryl ring in the 6-position of the pyridazine ring.